glp 1 therapy for weight loss Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription GLP-1 Injections for Weight Loss

Limited compounding may still occur for documented, patient-specific clinical needs, but the availability and regulatory landscape have tightened significantly

Improved Skin Health: Helps to inhibit melanin production, leading to a brighter, more even skin tone and a reduction in hyperpigmentation

The second study, this time from investigators at University Hospitals in Cleveland, also used the TriNetX database to examine the prevalence of gastroparesis in patients with type 2 diabetes who had been prescribed either a GLP-1 or a twincretin drug

Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks Patients on semaglutide lost an average of 13.7% of their body weight over the same period 47% more tirzepatide patients achieved 25% or greater body weight loss compared to semaglutide Tirzepatide also produced greater reductions in waist circumference across all dose comparisons A 2024 meta-analysis published in JAMA Internal Medicine analyzing real-world data from over 140,000 patients confirmed the same pattern: tirzepatide produced an average of 4.23 kg more weight loss than semaglutide across all doses and durations studied

Through correcting mineral deficiencies and dehydration, the boost IV drip enhances overall wellness (similar to a traditional Myers cocktail, with additional support)